However, it should be noted that the adaptive antioxidative effects of Nrf2 cannot prevent the progression of DKD in humans, whereas Nrf2 activation by genetic or pharmacological means is protective in mice. This evidence concerns the gene NFE2L2 and diabetic kidney disease.